"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 4 | 6 |
| 1995 | 5 | 1 | 6 |
| 1996 | 4 | 2 | 6 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 4 | 7 |
| 1999 | 11 | 3 | 14 |
| 2000 | 9 | 3 | 12 |
| 2001 | 5 | 3 | 8 |
| 2002 | 10 | 1 | 11 |
| 2003 | 14 | 5 | 19 |
| 2004 | 5 | 5 | 10 |
| 2005 | 14 | 3 | 17 |
| 2006 | 12 | 5 | 17 |
| 2007 | 8 | 4 | 12 |
| 2008 | 12 | 2 | 14 |
| 2009 | 10 | 5 | 15 |
| 2010 | 8 | 7 | 15 |
| 2011 | 7 | 6 | 13 |
| 2012 | 6 | 1 | 7 |
| 2013 | 9 | 8 | 17 |
| 2014 | 7 | 5 | 12 |
| 2015 | 12 | 7 | 19 |
| 2016 | 7 | 4 | 11 |
| 2017 | 8 | 1 | 9 |
| 2018 | 11 | 2 | 13 |
| 2019 | 4 | 1 | 5 |
| 2020 | 6 | 2 | 8 |
| 2021 | 4 | 5 | 9 |
| 2022 | 3 | 2 | 5 |
| 2023 | 1 | 5 | 6 |
| 2024 | 4 | 3 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Antiseizure medication-induced hypersensitivity reactions: Data from a large healthcare system. Seizure. 2024 Nov; 122:172-178.
-
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. Epilepsia Open. 2024 Oct; 9(5):1816-1825.
-
Mechanisms of neurodevelopmental toxicity of topiramate. Crit Rev Toxicol. 2024 Aug; 54(7):465-475.
-
Early Subclinical Status Epilepticus May Contribute to Developmental Delays in Infants With Tuberous Sclerosis Complex. Pediatr Neurol. 2024 Aug; 157:39-41.
-
Familial aggregation of seizure outcomes in four familial epilepsy cohorts. Epilepsia. 2024 Jul; 65(7):2030-2040.
-
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
-
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol. 2024 01 05; 26(1):7-24.
-
Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures. Epilepsia. 2023 10; 64(10):2550-2570.
-
Prehospital Treatment of Benzodiazepine-Resistant Pediatric Status Epilepticus with Parenteral Ketamine: A Case Series. Prehosp Emerg Care. 2023; 27(7):920-926.
-
Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children. Neurology. 2023 08 01; 101(5):e546-e557.